October 22, 2026 | 1:00 p.m. ET
SEO title: AR-Backed Working Capital: Read Past the 38-Day Average
Meta description: How can a medical practice free up cash when AR days keep rising? A 38-day average can hide real trouble. AR-Backed Working Capital funds the gap.
A practice can report a 38-day average in accounts receivable and still have a serious cash-concentration problem. The key takeaway: Days in AR is a headline measure, not a complete picture of which dollars are aging, and a few large, delayed claims can put real pressure on working capital.
For practice leaders, the response has two parts: examine the aging behind the average, then decide how to bridge the timing gap while addressing the causes. AR-Backed Working Capital can convert eligible receivables into working capital now, while Lean Six Sigma process improvement can help prevent avoidable delays from recurring.
What does the 2.4-day AR creep actually cost my practice?
A recent K-38 Consulting report says industry-median Days in AR rose by 2.4 days in 2026. It reports initial denial rates of 11.8%, up from 10.2% several years ago, and estimates each denied claim adds 15–30 days to the cycle. The report also notes that a denied claim can age retroactively from its date of service.
The financial effect can be material. For a practice billing $5 million annually, a 10-day change in AR days represents roughly $137,000 in working capital tied up, or released, according to K-38’s estimate. Its report cites an MGMA benchmark of fewer than 40 days, while many practices carry 35–55 days. A few additional days may look modest on a dashboard, but the cash-position impact is not.
How can my AR average look healthy while my cash position gets worse?
Because the overall AR-days calculation does not show how receivables are distributed by age, payer, or claim value. A practice can have a 38-day average and still have 25% of total receivables older than 90 days when a few high-dollar claims make up a large share of the aging balance. The average may look acceptable; the aging report may point to a concentrated liquidity risk.
Use cash position analysis to look beneath the headline metric. Break receivables down by aging bucket, payer, denial reason, and dollar amount. That turns financial planning from a broad estimate into a practical view of what is delaying cash and where leadership can act.
A five-point cash-concentration check for practice leaders
✅ Compare Days in AR with the dollar value and percentage of receivables over 90 days.
✅ Identify whether a small number of high-value claims account for an outsized share of aged AR.
✅ Segment aging by payer, service line, and denial category.
✅ Review authorization, eligibility, and documentation issues that start before claim submission.
✅ Model the cash impact of a 10-day change in AR days against payroll, vendors, and planned investment.
Why is reactive denial management making the gap bigger?
In a HIT Consultant article, Revecore CEO Noah Breslow argues that responding to denials only after they happen is no longer enough. The article cites Kodiak Solutions’ March 2026 benchmarking report, which reports that more than 2,300 hospitals lost over $48 billion in 2025 to final denials and uncollected patient balances. A 25% increase over 2024.
That hospital-wide finding is not the same measure as a medical practice’s Days in AR. But it reinforces a shared operational lesson: appeals teams cannot, by themselves, prevent recurring front-end breakdowns. Eligibility checks, authorization confirmation, and clean documentation matter before a claim enters a payer’s review process.
White Coat Financial Partners can pair financing with Lean Six Sigma consulting to identify process bottlenecks, strengthen front-end controls, shorten the billing cycle, and reduce the long-term need for financing. The objective is not more administrative motion; it is finding money already earned and improving the process that converts services into cash.
How does AR-Backed Working Capital turn earned receivables into cash now?
With AR-Backed Working Capital, the practice keeps its own billing and collections; White Coat Financial Partners does not take possession of receivables, contact patients, or intervene in the billing process. This is a non-notification lending model: the practice maintains its patient relationships and control of its revenue cycle.
We lend against the aggregate sum of monies due across total receivables, not individual claims. Repayment is structured to align with cash flow, with no compounding interest or open-ended discount rates. Lending is AR-backed, not based solely on personal credit scores, and the solution can scale from solo practices to multi-location groups.
Traditional bank lines often hinge on personal credit and collateral, with underwriting that may take weeks. AR-backed review considers the receivables themselves; approval may be available within 24–48 hours, depending on the file. For details on accounts receivable financing, White Coat Financial Partners offers a forward-looking conversation focused on your cash position and operating needs.
How can equipment leasing complement working capital?
Equipment leasing can provide access to imaging, diagnostic, or AI tools without requiring the practice to pay the full purchase price upfront. A lease pays for the use of equipment rather than ownership, helping preserve capital for staffing, operations, and growth. Lease terms may also include options to upgrade or purchase equipment at the end of the term. Useful when technology needs change.
On the balance sheet, operating leases are treated as expenses on the P&L and do not appear as liabilities, which preserves debt capacity and keeps debt-to-equity ratios clean for future lending or an eventual M&A transaction. That structural advantage is why leasing is often the preferred route for practices positioning for acquisition financing or an exit: equipment access stays aligned with cash planning while the balance sheet stays unencumbered.
There is also a tax angle worth discussing with your accountant: under IRS Section 179 lessees may deduct the full lease payment as a business expense in the year of payment (check with your tax advisor to see if you qualify). Paired with AR-Backed Working Capital, leasing lets a practice bring in the technology that drives volume without absorbing depreciation or ownership risk, and upgrade options at the end of the term mean you can cycle into newer imaging, diagnostics, or AI tools as they mature.
Accounting is history. Financing is forward looking. White Coat Financial Partners brings unmatched expertise, a gold-standard focus on strategic capital management, and white-glove services to deliver forward looking financing that helps healthcare businesses build clarity, certainty, and strategic advantage.
Frequently asked questions
Does AR-Backed Working Capital change who manages my billing?
No. The practice retains its billing and collections, and White Coat Financial Partners does not contact patients or intervene in the billing process.
How fast can a practice get funded?
Approval may be available in 24–48 hours, depending on the receivables and the file. Timing is subject to review.
Should we fix the billing process or finance the gap, or both?
They can work together. Financing can address a near-term cash need, while Lean Six Sigma consulting targets root causes that extend the billing cycle.
Take the next step
For a confidential discussion about AR-Backed Working Capital and medical practice financing, contact White Coat Financial Partners at 910-688-5077. Together, we can assess your receivables, clarify your cash position, and build a forward-looking plan.
About the Author
Stuart D. Anderson is the founder and President of White Coat Financial Partners, a Fayetteville, NC-based firm providing specialized financial and advisory services for healthcare professionals and organizations. With deep expertise in AR-backed working capital, equipment leasing, M&A brokerage, and Lean Six Sigma process optimization, Stuart helps medical practices unlock capital, streamline operations, and achieve long-term financial stability. Connect with Stuart on LinkedIn.
